Drugs / ST20
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00614016 | Jan → Apr 2008 | — | HemaQuest Pharmaceuticals Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ST20 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00614016 ↗ |
| Known as | Sodium ST20 | “A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Sodium ST20 in Healthy Volunteers” NCT00614016 ↗ |
| Route | Oral | “single administration of oral dosage form” NCT00614016 ↗ |